APA (7th ed.) Citation

H, D., L, C., T, T., R, S., K, Y., C, W., . . . Y, D. (2025). Mechanism-guided pharmacotherapy for cardiometabolic multimorbidity: From pathophysiology to phenotype-prioritized treatment. Frontiers in endocrinology, 16, 1724965. https://doi.org/10.3389/fendo.2025.1724965

Chicago Style (17th ed.) Citation

H, Dong, et al. "Mechanism-guided Pharmacotherapy for Cardiometabolic Multimorbidity: From Pathophysiology to Phenotype-prioritized Treatment." Frontiers in Endocrinology 16 (2025): 1724965. https://doi.org/10.3389/fendo.2025.1724965.

MLA (9th ed.) Citation

H, Dong, et al. "Mechanism-guided Pharmacotherapy for Cardiometabolic Multimorbidity: From Pathophysiology to Phenotype-prioritized Treatment." Frontiers in Endocrinology, vol. 16, 2025, p. 1724965, https://doi.org/10.3389/fendo.2025.1724965.